355 results
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
29 May 24
Departure of Directors or Certain Officers
7:34am
of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including statements regarding the future … and payment of services fees from our Bioservices customers; the results of pending stockholder litigation and government investigations
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
this press release.
SAFE HARBOR STATEMENT
This press release includes forward-looking statements within the meaning of the Private Securities Litigation … of services fees from our Bioservices customers; the results of pending stockholder litigation and government investigations and their potential impact
8-K
EX-99.2
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact … litigation and government investigations and their potential impact on our business; our ability to comply with the operating and financial covenants required
8-K
EBS
Emergent Biosolutions Inc
1 May 24
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
4:05pm
forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
4:05pm
Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, including statements regarding the expected
8-K
EX-99.1
7zd3pc9ypr
30 Apr 24
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
5:22pm
8-K
EX-99.2
rdgg9 m7myrqiq
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-99.1
m80asqby824k
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-99.1
lk82zqcdajb6wc 456p
21 Feb 24
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
7:25am
8-K
EX-99.1
rwx550
11 Jan 24
Other Events
7:41am
8-K
EX-99.2
mqxrmhlpa4t2ofg
9 Jan 24
Regulation FD Disclosure
8:40am
8-K
EX-99.1
cm3e3i6llw2ghf4s7g
9 Jan 24
Regulation FD Disclosure
8:40am
8-K
EX-99.1
ggdks9
28 Nov 23
Other Events
7:15am
8-K
EX-99.1
uqw56 zo5
24 Nov 23
Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing
7:17am
8-K
c8zeyiwc54mbag
16 Nov 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:11pm
8-K
EX-99.1
nwv1x
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm